OUR APPROACH & TECHNOLOGY

Single-Cell Response

Unraveling the complexity of biology through technology

We create a platform that combines proprietary methods of mapping cellular responses, single-cell genomics, and data science to build predictive models of disease biology and drug response to de-risk and accelerate traditional drug discovery and development.

Our QuRIE-seq technology generates unique data that allows for comprehensive, high-throughput analysis of transcriptome, membrane and intracellular proteome and phosphoproteome at single-cell resolution. This technology characterizes thousands of cells, capturing cell response heterogeneity and identifying rare subpopulations missed by bulk experiments, effectively replacing many incompatible analytical tools.

Eroom's Law

There is an increasing inefficiency in drug discovery, where the number of new drugs approved per billion dollars spent has halved every nine years since the 1950’s.

It contrasts with the rapid advancements in technology, highlighting that despite scientific progress, developing new drugs has become progressively more difficult and expensive.